The company specialises in the performance of mRNA tests and intends to carry out a clinical trial aimed at obese patients to obtain the CE mark, while strengthening the B2B area of the company.
Exheus, the start-up that analyses the expression of genes to improve people’s quality of life, has opened a €600,000 funding round with Capital Cell. This amount will allow them to continue developing their technology, which is capable of sequencing mRNA from a small sample of blood and associating gene expression in more than 320 metabolic pathways that act as biomarkers of the parameters of the individual’s body, analysing all those variations that are outside the normal range to improve and prevent health problems.

With the data collected, the company divides its business strategy into two lines. The first (Nutri Diet) focuses on nutrition and considers it a main pillar in health prevention, while the second (Exheus Blue Boost) focuses on the study of biological markers focused on sports performance. A differential point of this test is that it evaluates the response of the user’s genes to the different physiological stimuli that the body receives, such as physical exercise, rest or food.

Set up within the framework of the Venture Builder programme ‘The Collider’ of the Mobile World Capital Barcelona Foundation, Exheus was born out of the doctoral thesis, defended at the Universitat Politècnica de Catalunya – BarcelonaTech (UPC), of the researcher Emma Roca. Together with José Manuel Soria, principal investigator of the Genomics of Complex Diseases Research Group of the Research Institute of the Hospital de Sant Pau – IIB Sant Pau, Alexandre Perera, physicist, expert in Artificial Intelligence and director of the Centre for Research in Biomedical Engineering (CREB) of the UPC, in charge of developing the algorithms that allow automatic evaluation of the expression of metabolic pathways, as well as the company Summit SL. It currently has a staff of twenty employees.

All the information about the funding round here: https://capitalcell.es/campaign/exheus/

For more information about the spin-off Exheus, you can visit their website: https://exheus.com/

This project is co-financed by the European Union through the European Regional Development Fund (ERDF).